The clinical use of risk assessment

被引：16
|
作者：
Glancy, GD
Chaimowitz, G
机构：
[1] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[2] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada
来源：
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE | 2005年 / 50卷 / 01期
关键词：
risk assessment; duty to warn andprotect; actuarial tools;
D O I：
10.1177/070674370505000104
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
In this paper, we argue that risk assessment should be considered a part of daily clinical psychiatric practice. We discuss the advantages and disadvantages of various risk assessment procedures. In the event that a high risk for violence is present, we advise on strategies for discharging our duty to protect the public. Finally, by way of an illustrative case, we apply theory to practice and discuss the issues of risk management and risk reduction essential to a modem approach to psychiatry.
引用
收藏
页码：12 / 17
页数：6
相关论文
共 50 条
  • [41] The use of quantitative risk assessment in HACCP
    Hoornstra, E
    Northolt, MD
    Notermans, S
    Barendsz, AW
    [J]. FOOD CONTROL, 2001, 12 (04) : 229 - 234
  • [42] USE OF BIOLOGICAL MARKERS IN RISK ASSESSMENT
    MCMILLAN, A
    WHITTEMORE, AS
    SILVERS, A
    DICICCIO, Y
    [J]. RISK ANALYSIS, 1994, 14 (05) : 807 - 813
  • [43] THE USE OF EPIDEMIOLOGICAL DATA IN RISK ASSESSMENT
    SWAEN, GMH
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1988, 8 (04) : 422 - 430
  • [44] USE OF MECHANISTIC DATA IN RISK ASSESSMENT
    GALLO, MA
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 69 - ENVR
  • [45] Making use of cancer risk assessment
    Omenn, GS
    [J]. ISSUES IN SCIENCE AND TECHNOLOGY, 1996, 12 (04) : 29 - 32
  • [46] The use of ergonomics registers - Risk assessment
    Richter, A
    [J]. QUALITY OF WORK AND PRODUCTS IN ENTERPRISES OF THE FUTURE, 2003, : 807 - 809
  • [47] USE OF MECHANISTIC DATA IN RISK ASSESSMENT
    PARKER, JC
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 76 - AGRO
  • [48] The use of apolipoprotein B in risk assessment
    不详
    [J]. FUTURE CARDIOLOGY, 2006, 2 (03) : 252 - 252
  • [49] The use of in vitro data in risk assessment
    Bernauer, U
    Oberemm, A
    Madle, S
    Gundert-Remy, U
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (03) : 176 - 181
  • [50] Use assessment of pharmaceuticals - Chance or risk?
    Wenz, J
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (20) : 1135 - 1136
12345